Daniel Laverick , VP , Head of Digital and Data Solutions at Zuellig Pharma , tells us about innovations in blockchain technology and working with MSD .
Daniel Laverick , VP , Head of Digital and Data Solutions at Zuellig Pharma , tells us about innovations in blockchain technology and working with MSD .
Laverick focuses on developing customerfacing innovations to enable secure ordering and ensuring the pharmaceutical supply chains are visible .
Zuellig Pharma was founded nearly 100 years ago , and has grown to become one of the largest healthcare service provider groups in Asia , valued at US $ 13 billion . Key products include the online ordering portal eZRx , and eZVax , a solution that provides governments , local health authorities and the private sector with end-to-end vaccine management .
The latter is primarily used for the COVID-19 vaccine currently , but
Laverick says the plan is for this to be used for any vaccine in the future .
Another important service is the eZTracker solution , which uses blockchainbased technology to drive transparency and visibility in the supply chain for product authentication . eZTracker ’ s partnership with MSD began in 2020 when eZTracker was deployed in Hong Kong to enhance the traceability of Gardasil ® 9 , MSD ’ s HPV vaccine .
Laverick explains how eZTracker works : “ As the vaccines move through various handover points in the supply chain , the products ’ data points are loaded into eZTracker ’ s secure blockchain ledger , and this ensures it can ’ t be tampered with . Users such as healthcare professionals and patients are able to verify the authenticity of the vaccines by scanning a unique data matrix code on the product pack .”
Collaboration between the two companies has grown since then . “ We work closely with MSD ’ s Connected Channel globally , as well as the regional teams , on expanding the use and outreach of eZTracker ” Laverick says . “ It really is to support the initiative that MSD has , to go from plant to patient and track and trace its product and material movements .”
Zuellig Pharma recently completed a project to explore how blockchain technology can be leveraged further to provide more visibility around inventory and streamline ordering processes . Next , Zuellig Pharma is looking at ways MSD can have a self-operated node to be in control of the data the blockchain contains .
“ We have a very strong partnership with MSD ” he adds . “ We look forward to continuing to build on this , and seeing how we can support digitally enabled end-to-end supply chains , and the vision to track from plant to patient .”
Learn more